[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas]

Rev Esp Med Nucl. 2000 Jun;19(3):225-41.
[Article in Spanish]
No abstract available

Publication types

  • Evaluation Study
  • Review

MeSH terms

  • Algorithms
  • Animals
  • Binding, Competitive
  • Biomarkers, Tumor / analysis*
  • Clinical Trials, Phase I as Topic
  • Gastrointestinal Neoplasms / chemistry
  • Gastrointestinal Neoplasms / diagnostic imaging*
  • Gastrointestinal Neoplasms / metabolism
  • Gastrointestinal Neoplasms / therapy
  • Humans
  • Indium Radioisotopes* / pharmacokinetics
  • Indium Radioisotopes* / therapeutic use
  • Neoplasm Metastasis
  • Neoplasm Proteins / analysis*
  • Neoplasm Staging / methods*
  • Neuroendocrine Tumors / chemistry
  • Neuroendocrine Tumors / diagnostic imaging*
  • Neuroendocrine Tumors / metabolism
  • Neuroendocrine Tumors / therapy
  • Neuropeptides / metabolism
  • Octreotide / analogs & derivatives*
  • Octreotide / pharmacokinetics
  • Octreotide / therapeutic use
  • Pancreatic Neoplasms / chemistry
  • Pancreatic Neoplasms / diagnostic imaging*
  • Pancreatic Neoplasms / metabolism
  • Pancreatic Neoplasms / therapy
  • Pentetic Acid / analogs & derivatives*
  • Pentetic Acid / pharmacokinetics
  • Pentetic Acid / therapeutic use
  • Radiology, Interventional
  • Radionuclide Imaging / methods
  • Radiopharmaceuticals* / pharmacokinetics
  • Radiopharmaceuticals* / therapeutic use
  • Receptors, Somatostatin / analysis*
  • Sensitivity and Specificity
  • Somatostatin / chemistry
  • Somatostatin / physiology

Substances

  • Biomarkers, Tumor
  • Indium Radioisotopes
  • Neoplasm Proteins
  • Neuropeptides
  • Radiopharmaceuticals
  • Receptors, Somatostatin
  • SDZ 215-811
  • Somatostatin
  • Pentetic Acid
  • Octreotide